The role of Blastocystis hominis (BH) as a pathogen in the human body is shrouded in controversy. Very commonly found in society, this mysterious and elusive parasite still baffles scientific and medical communities. Having an understanding of what is currently known about the BH microbe, and being aware of the use of non-pharmaceutical measures, will guide many therapists towards safe and effective individual protocols, where treatment, regardless of symptom status, can increase overall health and wellbeing.
GIT microbiota and mitochondrial crosstalk appears to occur primarily via complex endocrine, humoural and immune pathway signalling.
Recent studies have observed differences in the local breast microbiome of subjects with malignant breast cancer compared to those with benign tumours or who were disease-free.
Looking at the complex interplay of exogenous and endogenous toxicity and the gut microbiota.
SIBO causes inflammation both in the gut and systemically and is notoriously difficult to treat, with high relapse rates, so finding new treatment protocols for SIBO is hugely beneficial.